NewGenIvf Group Price to Free Cash Flow Ratio 2023-2023 | NIVF

NewGenIvf Group price to free cash flow ratio from 2023 to 2023. Price to free cash flow ratio can be defined as

NewGenIvf Group Price to Free Cash Flow Ratio 2023-2023 | NIVF

NewGenIvf Group price to free cash flow ratio from 2023 to 2023. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$121.5B
Cencora (COR)$44.3B
ICON (ICLR)$23.6B
DiDi Global (DIDIY)$23.3B
Avantor (AVTR)$17.6B
Natera (NTRA)$15.5B
Revvity (RVTY)$15.5B
Viatris (VTRS)$13.8B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$11.7B
Medpace Holdings (MEDP)$10.3B
Charles River Laboratories (CRL)$10.2B
Sonic Healthcare (SKHHY)$9.1B
Doximity (DOCS)$8B
HealthEquity (HQY)$7B
Bausch + Lomb (BLCO)$6.7B
PACS (PACS)$6B
Organon (OGN)$4.9B
Life Times (LTH)$4.8B
Sotera Health (SHC)$4.7B
Surgery Partners (SGRY)$4.1B
Concentras Parent (CON)$2.8B
Ardent Health Partners (ARDT)$2.6B
GoodRx Holdings (GDRX)$2.6B
BrightSpring Health Services (BTSG)$2.6B
Alignment Healthcare (ALHC)$2.2B
Premier (PINC)$2B
Ryman Healthcare (RYHTY)$2B
AMN Healthcare Services Inc (AMN)$1.6B
CareDx (CDNA)$1.6B